Victory Capital Management’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$344K Sell
12,996
-144
-1% -$3.82K ﹤0.01% 2128
2025
Q1
$317K Sell
13,140
-8,857
-40% -$214K ﹤0.01% 2124
2024
Q4
$885K Buy
21,997
+2,689
+14% +$108K ﹤0.01% 1860
2024
Q3
$1.22M Sell
19,308
-9,608
-33% -$608K ﹤0.01% 1700
2024
Q2
$1.53M Sell
28,916
-163,043
-85% -$8.64M ﹤0.01% 1526
2024
Q1
$15.7M Buy
191,959
+154,459
+412% +$12.7M 0.02% 902
2023
Q4
$698K Buy
37,500
+3,049
+9% +$56.7K ﹤0.01% 1871
2023
Q3
$381K Sell
34,451
-784,661
-96% -$8.69M ﹤0.01% 2061
2023
Q2
$13.3M Buy
819,112
+553,792
+209% +$8.98M 0.01% 929
2023
Q1
$4.42M Buy
+265,320
New +$4.42M 0.01% 1223
2021
Q4
Sell
-10,204
Closed -$64K 2855
2021
Q3
$64K Sell
10,204
-379
-4% -$2.38K ﹤0.01% 2668
2021
Q2
$63K Sell
10,583
-86,592
-89% -$515K ﹤0.01% 2654
2021
Q1
$615K Sell
97,175
-4,787
-5% -$30.3K ﹤0.01% 2098
2020
Q4
$574K Sell
101,962
-5,984
-6% -$33.7K ﹤0.01% 2012
2020
Q3
$628K Sell
107,946
-42,029
-28% -$245K ﹤0.01% 1878
2020
Q2
$1.08M Sell
149,975
-150,997
-50% -$1.09M ﹤0.01% 1695
2020
Q1
$1.41M Buy
300,972
+138,674
+85% +$649K ﹤0.01% 1734
2019
Q4
$1.3M Buy
162,298
+3,618
+2% +$29K ﹤0.01% 1661
2019
Q3
$1.09M Buy
158,680
+153,057
+2,722% +$1.05M ﹤0.01% 1680
2019
Q2
$47K Hold
5,623
﹤0.01% 1741
2019
Q1
$56K Hold
5,623
﹤0.01% 1703
2018
Q4
$43K Sell
5,623
-1,071
-16% -$8.19K ﹤0.01% 1705
2018
Q3
$117K Buy
6,694
+880
+15% +$15.4K ﹤0.01% 1652
2018
Q2
$55K Sell
5,814
-599,980
-99% -$5.68M ﹤0.01% 1753
2018
Q1
$2.65M Buy
605,794
+410,864
+211% +$1.8M 0.01% 996
2017
Q4
$791K Buy
+194,930
New +$791K ﹤0.01% 1269